Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Y-mAbs Therapeutics Inc.

    NASDAQ: YMAB · Real-Time Price · USD
    3.89
    0.03 (0.78%)
    At close: May 16, 2025, 9:50 AM

    Y-mAbs Therapeutics Revenue

    Y-mAbs Therapeutics reported an annual revenue of $87.69M, reflecting a 3.38% growth. For the quarter ending March 31, 2025, Y-mAbs Therapeutics generated $20.9M in revenue.
    Revenue (ttm)
    $87.69M
    Revenue Growth
    3.38%
    Price / Sales Ratio
    3.96
    Revenue / Employee
    $843.13K
    Employees
    104
    Market Cap
    176.03M

    Revenue Chart

    Revenue History

    Fiscal Year End Revenue % Change
    Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

    Add to Watchlist